Silencing of HIV by hairpin-loop-structured DNA oligonucleotide

FEBS Letters

Volumn 580, Issue 14, 2006, Pages 3545-3550

  Moelling, Karin ^a,b   Abels, Susanne ^a   Jendis, Joerg ^c   Matskevich, Alexey ^a   Heinrich, Jochen ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c NONE   (Switzerland)

Author keywords

Polypurine tract; Reverse transcriptase RNase H; Sequence specific RNA degradation; siRNA; Triple helix

Indexed keywords

ANTIGEN P24; ANTIVIRUS AGENT; COMPLEMENTARY DNA; NUCLEIC ACID; NUCLEOTIDE; OLIGODEOXYNUCLEOTIDE;

ANTIGEN EXPRESSION; ARTICLE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; EVOLUTIONARY HOMOLOGY; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VIRUS INFECTION; VIRUS REPLICATION;

BASE SEQUENCE; CELL LINE; DNA PRIMERS; DNA, VIRAL; GENE SILENCING; HIV-1; HUMANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VIRUS REPLICATION;

EID: 33646916634     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2006.05.033     Document Type: Article

References (24)

1. Moelling K., Bolognesi D.P., Bauer H., Büser W., Plassman H.W., and Hausen P. Association of the viral reverse transcriptase with an enzyme degrading the RNA moiety of RNA-DNA hybrids. Nature New Biol. 234 (1971) 240-243
2. Hansen J., Schulze T., Mellert W., and Moelling K. Identification and characterization of HIV-specific RNase H by monoclonal antibody. EMBO J. 7 (1988) 239-243
3. Tisdale M., Schulze T., Larder B.A., and Moelling K. Mutations within the RNase H domain of human immunodeficiency virus type 1 reverse transcriptase abolish virus infectivity. J. Gen. Virol. 72 (1991) 59-66
4. Wohrl B.M., and Moelling K. Interaction of HIV-1 ribonuclease H with polypurine tract containing RNA-DNA hybrids. Biochemistry 29 (1990) 10141-10147
5. Wohrl B.M., Volkmann S., and Moelling K. Mutations of a conserved residue within HIV-1 ribonuclease H affect its exo- and endonuclease activities. J. Mol. Biol. 220 (1991) 801-818
6. Volkmann S., Jendis J., Frauendorf A., and Moelling K. Inhibition of HIV-1 reverse transcription by triple-helix forming oligonucleotides with viral RNA. Nucleic Acids Res. 23 (1995) 1204-1212 (Erratum in: Nucleic Acids Res. 23, 3804)
7. Reicin A.S., Kalpana G., Paik S., Marmon S., and Goff S. Sequences in the human immunodeficiency virus type 1 U3 region required for in vivo and in vitro integration. J. Virol. 69 (1995) 5904-5907
8. Sarafianos S.G., Das K., Tantillo C., Clark Jr. A.D., Ding J., Whitcomb J.M., Boyer P.L., Hughes S.H., and Arnold E. Crystal structure of HIV-1 reverse transcriptase in complex with a polypurine tract RNA:DNA. EMBO J. 20 (1996) 1449-1461
9. Xiong Y., and Sundaralingam M. Crystal structure and conformation of a DNA-RNA hybrid duplex with a polypurine RNA strand: d(TTCTTBr5CTTC)-r(GAAGAAGAA). Structure 6 (1998) 1493-1501
10. In: Malvy C., Harel-Bellan A., and Pritchard L.L. (Eds). Triple Helix Forming Oligonucleotides (1999), Kluwer Academic Publishers, Boston/Dordrecht/London
11. Jendis J., Strack B., and Moelling K. Inhibition of replication of drug-resistant HIV type 1 isolates by polypurine tract-specific oligodeoxy-nucleotide TFO A. AIDS Res. Hum. Retroviruses 14 (1998) 999-1005
12. Jendis J., Strack B., Volkmann S., Boni J., and Moelling K. Inhibition of replication of fresh HIV type 1 patient isolates by a polypurine tract-specific self-complementary oligodeoxynucleotide. AIDS Res. Hum. Retroviruses 12 (1996) 1161-1168
13. Salahuddin S.Z., Markham P.D., Wong-Staal F., Franchini G., Kalyanaraman V.S., and Gallo R.C. Restricted expression of human T-cell leukemia-lymphoma virus (HTLV) in transformed human umbilical cord blood lymphocytes. Virology 129 (1983) 51-64
14. Lusso P., Cocchi F., Balotta C., Markham P.D., Louie A., Farci P., Pal R., Gallo R.C., and Reitz Jr. M.S. Growth of macrophage-tropic and primary human immunodeficiency virus type 1 (HIV-1) isolates in a unique CD4+ T-cell clone (PM1): failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1. J. Virol. 69 (1995) 3712-3720
15. Charneau P., Alizon M., and Clavel F. A second origin of DNA plus-strand synthesis is required for optimal human immunodeficiency virus replication. J. Virol. 66 (1992) 2814-2820
16. Faria M., Wood C.D., Perrouault L., Nelson J.S., Winter A., White M.R., Helene C., and Giovannangeli C. Targeted inhibition of transcription elongation in cells mediated by triplex-forming oligonucleotides. Proc. Natl. Acad. Sci. 97 (2000) 3862-3867
17. Vasquez K.M., Narayanan L., and Glazer P.M. Specific mutations induced by triplex-forming oligonucleotides in mice. Science 290 (2000) 530-533
18. Hiratou T., Tsukahara S., Miyano-Kurosaki N., Takai K., Yamamoto N., and Takaku H. Inhibition of HIV-1 replication by a two-strand system (FTFOs) targeted to the polypurine tract. FEBS Lett. 456 (1999) 186-190
19. Gaidamakov S.A., Gorshkova I.I., Schuck P., Steinbach P.J., Yamada H., Crouch R.J., and Cerritelli S.M. Eukaryotic RNases H1 act processively by interactions through the duplex RNA-binding domain. Nucleic Acids Res. 33 (2005) 2166-2175
20. Song J.J., Smith S.K., Hannon G.J., and Joshua-Tor L. Crystal structure of Argonaute and its implications for RISC slicer activity. Science 305 (2004) 1434-1437
21. Yuan Y.-R., Pei Y., Ma J.-B., Kuryavyi V., Zhadina M., Meister G., Chen H.-Y., Dauter Z., Tuschl T., and Patel D.J. Crystal structure of A. aeolicus Argonaute, a site-specific DNA-guided endoribonuclease, provides insights into RISC-mediated mRNA cleavage. Mol. Cell 19 (2005) 405-419
22. Tsuchihashi Z., and Brown P.O. DNA strand exchange and selective DNA annealing promoted by the human immunodeficiency virus type 1 nucleocapsid protein. J. Virol. 68 (1994) 5863-5870
23. Herschlag D., Khosla M., Tsuchihashi Z., and Karpel R.L. An RNA chaperone activity of non-specific RNA binding proteins in hammerhead ribozyme catalysis. EMBO J. 15 (1994) 2913-2924 (Erratum in: EMBO J. 13, 3926)
24. Müller G., Strack B., Dannull J., Sproat B., Surovoy A., Jung G., and Moelling K. Amino acid requirements of the nucleocapsid protein of HIV-1 for increasing catalytic activity of a Ki-ras ribozyme in vitro. J. Mol. Biol. 242 (1994) 422-429